Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Cancer × Dasatinib × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia, Myeloid, Chronic-Phase 7 Recurrence 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Breast Neoplasms 5 Multiple Myeloma 4 Leukemia, Myeloid, Acute 4 Burkitt Lymphoma 4 Waldenstrom Macroglobulinemia 3 Prostatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Lung Neoplasms 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia 3 Immunoblastic Lymphadenopathy 3 Hodgkin Disease 3 Squamous Cell Carcinoma of Head and Neck 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2

Interventions

Nivolumab 4 Ipilimumab 3 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 tilsotolimod 1 relatlimab 1 linrodostat 1 figitumumab 1 Valganciclovir 1 Tablets 1 Surveys and Questionnaires 1 Sunitinib 1 Paclitaxel 1 LY2584702 1 EC145 1 Dasatinib 1 Chlorogenic Acid 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02750514 2021-03-22

FRACTION-Lung

Bristol-Myers Squibb

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡